Best in Class Anti-Infectives
Trius Therapeutics is a biopharmaceutical company focused
on the discovery, development and commercialization
of innovative antibiotics for serious, life-threatening infections
on the discovery, development and commercialization
of innovative antibiotics for serious, life-threatening infections
In The News
May 13, 2013
Trius Announces Notice of Allowance of U.S. Patent Application Related to Tedizolid Phosphate Combination With Daptomycin »
Events & Publications
